RUNX1 and acute lymphoblastic leukemia: Despite this, results from another study showed that a high incidence (20 to 24%) of the ETV6/RUNX1 fusion in relapsed patients with ALL, thereby casting doubt as to the prognostic significance of this genetic alteration (11).